References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Eiermannetal(1997)TheinvolvementofCYP1A2andCYP3A4inthemetabolismofclozapine.Br.J.Clin.Pharmacol.44439PMID:9384460
Ambrusteretal(2007)EvolvingthelocktofitthekeytocreateafamilyofGprotein-coupledreceptorspotentlyactivatedbyaninertligand.Proc.Natl.Acad.Sci.U.S.A.1045163PMID:17360345
Zamanetal(2014)LMO4isessentialforparaventricularhypothalamicneuronalactivityandcalciumchannelexpressiontopreventhyperphagia.J.Neurosci.34140PMID:24381275
Gomezetal(2017)Chemogeneticsrevealed:DREADDoccupancyandactivationviaconvertedclozapine.Science357503PMID:28774929
Rothetal(2016)DREADDsforNeuroscientists.Neuron89683PMID:26889809
Nakajimaetal(2016)Gs-coupledGPCRsignallinginAgRPneuronstriggerssustainedincreaseinfoodintake.Nat.Commun.810268PMID:26743492
Keywords:ClozapineN-oxidedihydrochloride,supplier,Clozapine,N-oxide,2HCl,metabolite,5HT2A/2C,non-selective,SEROtonin,5HT2C,5HT2,5HT2A,dopaminergic,dopamine,antagoNISTs,D4,DREADDs,Ligands,muscarnic,designer,receptors,CNO,water,soluble,DREADDs,Multidrug,Transporters,Non-selective,Dopamine,5-HT2A,Receptors,5-HT2C,Receptors,DREADDs,TocrisBioscience